新生物、骨髄性白血病、急性の臨床試験
合計8323件
-
Masonic Cancer Center, University of Minnesota完了
-
Dana-Farber Cancer InstituteBoston Children's Hospital; Brigham and Women's Hospital完了
-
Cooperative Study Group A for Hematology完了
-
Hoffmann-La Roche完了
-
Wake Forest University Health Sciences完了
-
Wake Forest University Health Sciences完了
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi Company終了しました
-
Masonic Cancer Center, University of Minnesota終了しました
-
Pfizer利用できない
-
Assistance Publique - Hôpitaux de Paris完了
-
Eisai Inc.終了しました
-
Hoffmann-La Roche完了
-
Merck Sharp & Dohme LLC終了しました
-
Genzyme, a Sanofi Company完了
-
Kyowa Kirin Co., Ltd.終了しました
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.募集
-
Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles; Pfizer; Jazz Pharmaceuticals終了しました
-
Calithera Biosciences, Inc終了しました
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)完了
-
Masonic Cancer Center, University of Minnesota完了
-
Masonic Cancer Center, University of Minnesota完了
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Bayer; Genzyme, a Sanofi Company; Amgen; Georgia Institute of Technology完了
-
European Organisation for Research and Treatment...完了
-
Cooperative Study Group A for Hematologyわからない
-
SGX Pharmaceuticals, Inc.終了しました
-
Wyeth is now a wholly owned subsidiary of Pfizer完了
-
Miltenyi Biotec B.V. & Co. KGUniversity of Chicago; Ohio State University; Masonic Cancer Center, University of Minnesota終了しました
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi Company終了しました
-
Masonic Cancer Center, University of MinnesotaMiltenyi Biomedicine GmbH引きこもった
-
University of Southern California終了しました
-
Millennium Pharmaceuticals, Inc.引きこもった
-
M.D. Anderson Cancer CenterEisai Inc.完了